These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8798969)

  • 21. SIVmac expressing hybrid envelope proteins containing HIV-1 V3 and/or C4 sequences is not competent for replication.
    Kirchhoff F; Morrison HG; Murray MG; Rennert P; Desrosiers RC
    AIDS Res Hum Retroviruses; 1994 Mar; 10(3):309-13. PubMed ID: 8018392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drift from the GPGRAF HIV-1 envelope V3 crown sequence in a North American inner city.
    Rencher SD; Lockey TD; Slobod KS; Hurwitz JL
    AIDS Res Hum Retroviruses; 1997 Apr; 13(6):527-8. PubMed ID: 9100996
    [No Abstract]   [Full Text] [Related]  

  • 23. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
    Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
    J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV type 1 subtypes in Argentina and genetic heterogeneity of the V3 region.
    Campodonico M; Janssens W; Heyndrickx L; Fransen K; Leonaers A; Fay FF; Taborda M; Van der Groen G; Fay OH
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):79-81. PubMed ID: 8825623
    [No Abstract]   [Full Text] [Related]  

  • 25. Single basic amino acid substitutions at position 302 or 320 in the V3 domain of HIV type 1 are not sufficient to alter the antiviral activity of dextran sulfate and heparin.
    Okada T; Gurney ME
    AIDS Res Hum Retroviruses; 1995 May; 11(5):571-5. PubMed ID: 7576913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients.
    Björndal A; Sönnerborg A; Tscherning C; Albert J; Fenyö EM
    AIDS Res Hum Retroviruses; 1999 May; 15(7):647-53. PubMed ID: 10331443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 intrapatient sequence diversity in the immunogenic V3 region.
    Korber B; Wolinsky S; Haynes B; Kunstman K; Levy R; Furtado M; Otto P; Myers G
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1461-5. PubMed ID: 1281659
    [No Abstract]   [Full Text] [Related]  

  • 28. Envelope V3 region sequences of Cuban HIV-1 isolates.
    Rolo FM; Miranda L; Wainberg MA; Gu Z; Lobaina L; Noa E; Mato J; Machado F; Martin Z
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):123-5. PubMed ID: 7749787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycoprotein 120 polymorphism in an HIV type 1 epidemic originating from a point source: nucleotide sequence analysis of variants with conserved V3 loop sequences.
    Bobkov A; Cheingsong-Popov R; Garaev M; Weber J
    AIDS Res Hum Retroviruses; 1996 Feb; 12(3):251-3. PubMed ID: 8835204
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical resistance to vicriviroc through adaptive V3 loop mutations in HIV-1 subtype D gp120 that alter interactions with the N-terminus and ECL2 of CCR5.
    Ogert RA; Hou Y; Ba L; Wojcik L; Qiu P; Murgolo N; Duca J; Dunkle LM; Ralston R; Howe JA
    Virology; 2010 Apr; 400(1):145-55. PubMed ID: 20172579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phylogenetic examination of HIV type 1 glycoprotein 120-V3 sequences in patients from rural Georgia.
    Roth WW; Womack C; Newman C; Essex M; Bond VC
    AIDS Res Hum Retroviruses; 1999 Mar; 15(4):399-403. PubMed ID: 10082125
    [No Abstract]   [Full Text] [Related]  

  • 32. Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors.
    Menzo S; Sampaolesi R; Vicenzi E; Santagostino E; Liuzzi G; Chirianni A; Piazza M; Cohen OJ; Bagnarelli P; Clementi M
    AIDS; 1998 Jun; 12(9):985-97. PubMed ID: 9662194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A unique, naturally occurring single-amino acid mutation in HIV type 1 V3 loop can discriminate between its cytopathicity and replication in vivo and in vitro.
    Wang B; Jozwiak R; Ge YC; Saksena NK
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):1019-21. PubMed ID: 9686649
    [No Abstract]   [Full Text] [Related]  

  • 35. [Molecular analysis of the principal neutralization epitope (V3 loop) of human immunodeficiency virus type 1 in Argentina].
    Gómez Carrillo M; Piccardo C; Libonatti O
    Rev Argent Microbiol; 1992; 24(2):91-101. PubMed ID: 1298019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients.
    Monno L; Brindicci G; Saracino A; Punzi G; Cibelli D; Lagioia A; Angarano G
    AIDS Res Hum Retroviruses; 2010 Mar; 26(3):365-72. PubMed ID: 20334572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate.
    Shibata J; Yoshimura K; Honda A; Koito A; Murakami T; Matsushita S
    J Virol; 2007 Apr; 81(8):3757-68. PubMed ID: 17251298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages).
    Briggs DR; Tuttle DL; Sleasman JW; Goodenow MM
    AIDS; 2000 Dec; 14(18):2937-9. PubMed ID: 11153675
    [No Abstract]   [Full Text] [Related]  

  • 39. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. V3-mediated heparin neutralization of HIV type 1.
    Javaherian K; Khiroya R; Quinlan C; Boyd JG; Hanham KA
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1421-3. PubMed ID: 7888195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.